Net prices of new antiobesity medications
Sign Up to like & getrecommendations! Published in 2024 at "Obesity"
DOI: 10.1002/oby.23973
Abstract: Glucagon‐like peptide‐1 receptor agonists (GLP1s) are effective antiobesity drugs and the subject of intense debate around insurance coverage due to the large prevalence of obesity and overweight. The estimation of the budget impact associated with… read more here.
Keywords: antiobesity medications; new antiobesity; prices new; net prices ... See more keywords